TY - JOUR AU - Baum M AU - Buzdar AU AU - Cuzick J AU - Forbes J AU - Houghton JH AU - Howell A AU - Sahmoud T TI - Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer. Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses JA - Cancer PY - 2003/// VL - 98 SP - 1802 EP - 1810 PB - Cancer Research UK M3 - 10.1002/cncr.11745 N1 - 10.1002/cncr.11745 UR - http://dx.doi.org/10.1002/cncr.11745 ER - TY - JOUR AU - Baum M AU - Buzdar AU AU - Cuzick J AU - Forbes J AU - Houghton JH AU - Klijn JG AU - Sahmoud T TI - Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial JA - Lancet PY - 2002/// VL - 359 SP - 2131 EP - 2139 PB - Cancer Research UK M3 - 10.1016/S0140-6736(02)09088-8 N1 - 10.1016/S0140-6736(02)09088-8 UR - http://dx.doi.org/10.1016/S0140-6736(02)09088-8 ER - TY - JOUR AU - Bonneterre J AU - Buzdar A AU - Nabholtz JM AU - Robertson JF AU - Thurlimann B AU - von Euler M AU - Sahmoud T AU - Webster A AU - Steinberg M TI - Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma JA - Cancer PY - 2001/// VL - 92 SP - 2247 EP - 2258 PB - Cancer Research UK M3 - 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y N1 - 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y UR - http://dx.doi.org/10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y ER - TY - JOUR AU - Geisler J AU - Dowsett M AU - Lonning PE TI - Letrozole is more effective than anastrozole in suppressing total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients JA - Am J Oncol Rev PY - 2002/// VL - 1 SP - 99 EP - 102 PB - Cancer Research UK ER - TY - JOUR AU - Goss PE AU - Ingle JN AU - Martino S AU - Robert NJ AU - Muss HB AU - Piccart MJ AU - Castiglione M AU - Tu D AU - Shepherd LE AU - Pritchard KI AU - Livingston RB AU - Davidson NE AU - Norton L AU - Perez EA AU - Abrams JS AU - Therasse P AU - Palmer MJ AU - Pater JL TI - A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer JA - N Engl J Med PY - 2003/// VL - 349 SP - 1793 EP - 1802 PB - Cancer Research UK M3 - 10.1056/NEJMoa032312 N1 - 10.1056/NEJMoa032312 UR - http://dx.doi.org/10.1056/NEJMoa032312 ER - TY - JOUR AU - Masamura S AU - Santner SJ AU - Heitjan DF AU - Santen RJ TI - Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells JA - J Clin Endocrinol Metab PY - 1995/// VL - 80 SP - 2918 EP - 2925 PB - Cancer Research UK M3 - 10.1210/jc.80.10.2918 N1 - 10.1210/jc.80.10.2918 UR - http://dx.doi.org/10.1210/jc.80.10.2918 ER - TY - JOUR AU - Mouridsen H AU - Gershanovich M AU - Sun Y AU - Perez-Carrion R AU - Boni C AU - Monnier A AU - Apffelstaedt J AU - Smith R AU - Sleeboom HP AU - Jaenicke F AU - Pluzanska A AU - Dank M AU - Becquart D AU - Bapsy PP AU - Salminen E AU - Snyder R AU - Chaudri-Ross H AU - Lang R AU - Wyld R AU - Bhatnagar A TI - Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group JA - J Clin Oncol PY - 2003/// VL - 21 SP - 2101 EP - 2109 PB - Cancer Research UK M3 - 10.1200/JCO.2003.04.194 N1 - 10.1200/JCO.2003.04.194 UR - http://dx.doi.org/10.1200/JCO.2003.04.194 ER - TY - JOUR AU - Nabholtz JM AU - Bonneterre J AU - Buzdar A AU - Robertson JF AU - Thurlimann B TI - Anastrozole (Arimidex[trade]) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results JA - Eur J Cancer PY - 2003/// VL - 39 SP - 1684 EP - 1689 PB - Cancer Research UK M3 - 10.1016/S0959-8049(03)00326-5 N1 - 10.1016/S0959-8049(03)00326-5 UR - http://dx.doi.org/10.1016/S0959-8049(03)00326-5 ER - TY - GEN TI - Breast cancer (PDQ[reg]): treatment JA - PY - 2004/// VL - SP - EP - PB - Cancer Research UK ER - TY - JOUR AU - Rose C AU - Vtoraya O AU - Pluzanska A AU - Davidson N AU - Gershanovich M AU - Thomas R AU - Johnson S AU - Caicedo JJ AU - Gervasio H AU - Manikhas G AU - Ben Ayed F AU - Burdette-Radoux S AU - Chaudri-Ross HA AU - Lang R TI - An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozole JA - Eur J Cancer PY - 2003/// VL - 39 SP - 2318 EP - 2327 PB - Cancer Research UK M3 - 10.1016/S0959-8049(03)00630-0 N1 - 10.1016/S0959-8049(03)00630-0 UR - http://dx.doi.org/10.1016/S0959-8049(03)00630-0 ER - TY - JOUR AU - Sainsbury R TI - Aromatase inhibition in the treatment of advanced breast cancer: is there a relationship between potency and clinical efficacy? JA - Br J Cancer PY - 2004/// VL - 90 SP - 1733 EP - 1739 PB - Cancer Research UK M3 - 10.1038/sj.bjc.6601731 N1 - 10.1038/sj.bjc.6601731 UR - http://dx.doi.org/10.1038/sj.bjc.6601731 ER -